Ferring Pharmaceuticals

This study observes how REKOVELLE, a fertility medication, works in real-world practice for Chinese women undergoing IVF or ICSI treatments. Researchers will follow 2,500 women across China to see how the drug affects pregnancy rates, safety, and treatment patterns. The study doe…

This Phase 3 trial is testing a gene therapy called nadofaragene firadenovec for people with a high-risk form of bladder cancer that has not responded to the standard BCG treatment. The study will see if the therapy, given alone or combined with chemotherapy or immunotherapy, can…

This study is testing whether a new gene therapy called nadofaragene firadenovec can help prevent cancer from returning in people with intermediate-risk bladder cancer that hasn't invaded the muscle layer. Participants will either receive the gene therapy or be observed without a…

This early-stage trial is testing a new gene therapy called nadofaragene firadenovec for adults with a specific type of low-grade bladder cancer in the upper urinary tract. The main goal is to see if the treatment is safe and tolerable. Doctors will also check if the therapy can …

This study is testing a medicine called CLENPIQ that cleans out the bowel before a colonoscopy in children aged 2 to 9 years. Researchers want to see how well it works, how safe it is, and how easy it is for children to take. They will compare results and ask children and parents…